United Therapeutics to take pulmonary hypertension drug to FDA for approvalnews2026-03-02T16:24:51+00:00March 2nd, 2026|Endpoints News|
UPDATED – EU to discuss gas supply security, energy prices as conflict progressesnews2026-03-02T16:24:00+00:00March 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
INSIGHT: Asian economies brace for import bill surge as oil prices climbnews2026-03-02T16:23:00+00:00March 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Asia C2 under threat of tight supply heading into Q2 amid MidEast hostilitiesnews2026-03-02T16:21:00+00:00March 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Brazil manufacturing stays in contraction as orders, output slide for 10th monthnews2026-03-02T16:16:00+00:00March 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Aardvark’s stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADCnews2026-03-02T16:14:18+00:00March 2nd, 2026|Endpoints News|
Lyle Shipley Joins Herculite as Director of Innovationnews2026-03-02T16:10:35+00:00March 2nd, 2026|Medical Device News Magazine|
European gas and power prices rise sharply as supply risk priced innews2026-03-02T16:05:00+00:00March 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Roche gets third pivotal win with MS drug, but liver signal could be a problemnews2026-03-02T15:25:33+00:00March 2nd, 2026|Endpoints News|
FDA lifts hold on second Intellia Phase 3 gene editing trialnews2026-03-02T15:23:14+00:00March 2nd, 2026|Endpoints News|
